Skip to content
HowShorted

Dyne Therapeutics, Inc. short interest in 2021

In 2021, Dyne Therapeutics, Inc.'s disclosed short interest ran from 3.07% of shares outstanding on 15 Jan 2021 to 5.42% on 31 Dec 2021, a change of +2.35 percentage points. The year's high was 5.42% on 31 Dec 2021 and its low 2.93% on 31 Aug 2021, averaging 4.00% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.61 days on 30 Nov 2021. Full history: Dyne Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Dyne Therapeutics, Inc. in 2021

2021 in figures

Start of year
3.07% (15 Jan 2021)
End of year
5.42% (31 Dec 2021)
Change
+2.35 pp
High
5.42% (31 Dec 2021)
Low
2.93% (31 Aug 2021)
Average
4.00%
Highest days to cover
15.61 (30 Nov 2021)
SEC filings marked
9

Every report in 2021

Dyne Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20213.07%9.03
29 Jan 20213.20%1.24results (8-K)
12 Feb 20213.53%4.43
26 Feb 20213.80%5.51
15 Mar 20214.14%5.0310-K filed, results (8-K)
31 Mar 20213.91%7.87
15 Apr 20214.36%9.25
30 Apr 20213.46%6.55
14 May 20213.71%11.2010-Q filed, results (8-K)
28 May 20213.58%12.02
15 Jun 20213.60%8.71
30 Jun 20213.58%4.15
15 Jul 20213.65%12.11
30 Jul 20213.99%10.91
13 Aug 20214.33%7.1710-Q filed, results (8-K)
31 Aug 20212.93%7.28
15 Sep 20213.22%4.97
30 Sep 20214.08%8.67
15 Oct 20214.20%13.40
29 Oct 20214.49%12.71
15 Nov 20215.16%12.5510-Q filed, results (8-K)
30 Nov 20215.31%15.61
15 Dec 20215.39%14.61
31 Dec 20215.42%12.96

See also: Dyne Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.